Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, April 2, 2018

Vendor Show Supporting OUHSC Students and Postdocs – The Graduate College, in

conjunction with the Graduate Student Association and the GREAT Committee, is hosting a vendor

show on Thursday, April 12th from 9:00am to 1:00pm in the Bird Library, 2nd floor foyer. This event

helps sponsor the Graduate Research Education And Technology (GREAT) Symposium, which is

a platform for Graduate College students and postdoctoral fellows to present their original research

and compete for travel awards, which in turn enables them to attend national scientific meetings.

All faculty, staff, postdocs, students, lab managers and technicians are encouraged to stop by to

support our students and postdocs by visiting our vendor show. Refreshments will be provided. For

more information, please contact the Graduate College (405-271-2085, or

or visit the 2018 GREAT Symposium website:



Save the Date - ORA Noon Conference

"Clinical Trials"

April 25, 2018

12pm-1pm, LIB299 (Auditorium)

For due dates after July 19, 2018, NIH will require that all applications involving one or more

independent clinical trials be submitted through an FOA specifically designated as “Clinical Trial

Required” or “Clinical Trial Optional”. These clinical trial-specific FOAs will include new review

questions that focus on the rationale and study design. This talk will cover clinical trial-specific review

criteria, the NIH definition of a clinical trial, the NIH tool to make the determination of whether a project

is a clinical trial, and will briefly discuss the ORA process.



2018 Oklahoma Geroscience Symposium“The Role of the IGF1/Insulin Signaling Pathway

in Aging and Diabetes” is April 6, 2018 at the Wileman Auditorium, Oklahoma Medical Research

Foundation.  See attached document for additional information or go to: Geroscience Symposium.pdf?ver=2018-03-26-081639-270


NeuroMAP (CoBRE) Pilot Project Program Announcement (Year2) The Laureate Institute

for Brain Research (LIBR) is soliciting applications for the Pilot Project Program funded by its

NeuroMAP CoBRE.  The goals of the Pilot Project Program are (1) To provide a process for young

investigators to utilize data collected by NeuroMAP investigators to conduct secondary analyses,

which may provide sufficiently strong results to warrant consideration of a young investigator to

replace a NeuroMAP investigator in those outcomes outlined above. (2) To provide the ability to

examine highly novel and yet under-developed hypotheses that may lead to new CoBRE projects

in the future. (3) To enable computational and statistical experts to mine the data collected to develop

better risk and outcome prediction approaches.

Deadline: May 15, 2018

Funding: July 1, 2018

Total Costs: $25,000

For more complete information see attachment Pre-proposal Guidelines.docx?ver=2018-01-08-074729-697


Oklahoma NSF EPSCoR 2018 Annual State conference is Tuesday, April

24, 2018 at the Embassy Suites Hotel in Oklahoma City, OK

Registration Deadlines

Registration w/Poster Submission:  March 20, 2018 5 p.m.

General Registration:  April 2, 2018 5 p.m.

Researchers from across the state will gather to highlight Oklahoma’s climate research efforts

associated with the OK NSF EPSCoR Research Infrastructure Improvement project “Adapting

Socio-Ecological Systems to Increased Climate Variability.” EPSCoR scientists and special

guest speakers will address topics including observing and modeling social and ecological

systems in a changing climate, and decision-support tools produced through the project. The

event will be held Tuesday, April 24, 2018, at the Embassy Suites Hotel (1815 S. Meridian Ave.)

in Oklahoma City. Check-in will open at 7:30 a.m.; the conference will be held from 8:20 a.m. –

4:30 p.m. For additional information see the attached document. 2018 State Conference.pdf?ver=2018-03-12-074351-240



Representatives from OTD will be highlighting OU life sciences research at the BIO International

Convention in June.  This is an opportunity to provide information about OU inventions and unique

resources (e.g., antibodies, assays/kits, cell lines, plasmids, reagents) you think may have

commercial value.  This is also an opportunity to receive feedback from major industry players

that can help support the commercial value of your research and guide research in a marketable

direction.  If you are interested in having your research or specialized materials profiled at BIO,

please contact Meredith Wilkerson, OTD Technology Development Associate:, no later than April 15th for more details.



Professional Grant Writing WorkshopApril 16-17, 2018 at Oklahoma State University

For additional information go to:



Oklahoma Center for Adult Stem Cell Research (OCASCR) – Grant proposal deadline is

September 6, 2018.  For additional information go to:




Guidelines and applications for each of these PHF grants can be found at:



Pre-Proposal Application for New Phase 1 COBRE Application

OUHSC is eligible to submit one new Phase 1 COBRE application for the January 24, 2019 deadline. 

The COBRE FOA can be found at:

In order to select the most competitive PI and research theme for this COBRE application there will

be an internal competition as described in the attached Guidelines. 

The Pre-Proposal Application is due April 20, 2018. Pre-proposal Guidelines.docx?ver=2018-01-08-074729-697




NINDS Notice to Clarify the Types of Clinical Trial Applications NINDS Will Support Under PA-18-159

"Mechanisms, Models, Measurement, & Management in Pain Research (R21 - Clinical Trial Optional)"



Notice of Change in Eligibility of Foreign Components and Revision of Award Budget for PAR-18-103

"Limited Competition: Small Grant Program for NIDDK K01/K08/K23 Recipients (R03 Clinical Trial

Optional)" (NOT-DK-18-011)


Notice of Change to Expiration Date on BRAIN Initiative: Theories, Models and Methods for

Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) (NOT-EB-18-012)


Notice of Change to PAR-17-233 "Core Infrastructure and Methodological Research for Cancer

Epidemiology Cohorts (U01)" (NOT-CA-18-055)


Notice of Change to RFA-MH-18-706, Pilot Effectiveness Trials for Treatment, Preventive and

Services Interventions (R34- Clinical Trial Required) (NOT-MH-18-030)


Notice of Changes in the Eligibility of Candidates Supported by the NIMH Administrative

Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during

Clinical training (Admin Supp) (NOT-MH-18-029)


Notice of Correction of Earliest Start Date for RFA-RM-18-018 Somatic Cell Genome Editing

Dissemination and Coordinating Center (U24 - Clinical Trial Not Allowed)" (NOT-RM-18-016)


Notice of Correction to the Specific Research Objectives for PA-16-175 Exploratory Grants in

Cancer Epidemiology and Genomics Research (R21)" (NOT-CA-18-057)


Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Advanced

Postdoctoral Career Transition Award to Promote Diversity (K99/R00) (NOT-NS-18-041)


Notice of NCI's Participation on PA-18-498, End-of-Life and Palliative Care Health Literacy:

Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional) (NOT-CA-18-032)


Notice of NCI's participation on PA-18-499, End-of-Life and Palliative Care Health Literacy:

Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional) (NOT-CA-18-033)


Notice of NIA Participation in PA-18-343: "Academic Research Enhancement Award

(R15 Clinical Trial Required) (NOT-AG-18-005)


Notice of NIA Participation in PA-18-676: "Research on the Health of Women of Understudied,

Underrepresented and Underreported (U3) Populations An ORWH FY18 Administrative Supplement

(Admin Supp Clinical Trial Optional)" (NOT-AG-18-007)


Notice of NIMH Participation in PA-18-488 "NIH Small Research Grant Program (Parent R03

Clinical Trial Not Allowed)" (NOT-MH-18-025)


Notice of NINR's Participation in PA-18-271 Strengthening the HIV Pre-Exposure Prophylaxis

(PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21 Clinical

Trial Optional) (NOT-NR-18-003)


Notice of NINR's Participation in PA-18-281 Strengthening the HIV Pre-Exposure Prophylaxis

(PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01 Clinical

Trial Optional) (NOT-NR-18-004)


Notice of NINR's Participation in PA-18-272 Targeted Basic Behavioral and Social Science and

Intervention Development for HIV Prevention and Care (R21 Clinical Trial Optional) (NOT-NR-18-005)


Notice of NINR's Participation in PA-18-273 Targeted Basic Behavioral and Social Science and

Intervention Development for HIV Prevention and Care (R01 Clinical Trial Optional) (NOT-NR-18-006)


Notice of Technical Assistance Webinar for RFA-HL-19-014: Stimulating T4 Implementation

Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood

Diseases and Sleep Disorders into Practice (STIMULATE) (NOT-HL-18-605)


Notice to Clarify the Types of Clinical Trials NIBIB Will Support Under PA-18-048 Zika Virus

(ZIKV) Complications (R21 Clinical Trial Optional) (NOT-EB-18-007)


Revision: Notice of Correction to Application Instructions in RFA-HL-19-008: Limited Competition:

Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)

(U01 Clinical Trial Not Allowed) (NOT-HL-18-609)



Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.




Assuring Radiation Protection (U18) (RFA-FD-18-021) – Deadline June 4, 2018


Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics

of Compositionally Different Topical Formulations (U01) (RFA-FD-18-010) – Deadline May 19, 2018


Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug

Products Using Non-Invasive Techniques (RFA-FD-18-012) – Deadline June 4, 2018


Characterize Skin Physiology Parameters Utilized in Dermal Physiologically-Based Pharmacokinetic

Model Development Across Different Skin Disease States (RFA-FD-18-017) Deadline May 29, 2018


Computational Fluid Dynamics (CFD) and Discrete Element Modeling (DEM) Approach for

Predictions of Dry Powder Inhaler (DPI) Drug Delivery (RFA-FD-18-014) – Deadline May 29, 2018

Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Clinical

Trial Not Allowed) (FRA-DA-19-004) – Deadline August 15, 2018


Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions

(D43 Clinical Trial Optional) (PAR-18-717) – Deadline August 23, 2018


Formulation Drug Product Quality Attributes in Dermal Physiologically-Based Pharmacokinetic

Models for Topical Dermatological Drug Products and Transdermal Delivery Systems

(RFA-FD-18-019) – Deadline May 28, 2018


International Bioethics Research Training Program (D43 Clinical Trial Optional) (PAR-18-716)

Deadline May 17, 2018


NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer's Disease Patient

Registry Cooperative Agreement Awards (U01 - Clinical Trial Not Allowed) (PAR-18-715)

Deadline June 5, 2018


Renewal Applications: Centers of Excellence in Regulatory Science and Innovation (RFA-FD-18-011)

Deadline June 4, 2018


Three-Dimensional Approach for Modeling Nasal Mucociliary Clearance via Computational Fluid

Dynamics (CFD) (RFA-FD-18-020) – Deadline June 4, 2018





College of Medicine Alumni Association (COMAA) – Deadline April 6, 2018

For additional information see the attachment.